Management of Anal Adenocarcinoma in Italy: National Survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group

1. Abstract
1.1. Aims: Anal canal adenocarcinoma is a rare neoplasm and there is currently no consensus on optimal management. Indeed, some clinical studies support trimodal therapy (similar to the treat- ment approach of locally advanced rectal adenocarcinoma) and others studies support definitive radiochemotherapy (similar to anal squamous cell carcinoma). Based on these considerations, a national survey was proposed aimed at evaluating the pattern of care in e anal adenocarcinoma patients in Italy to help standardize future treatment recommendations.